USANA To Build State-Of-The-Art Manufacturing Facility In China

SALT LAKE CITY, Nov. 4, 2013 /PRNewswire/ -- USANA Health Sciences Inc. (NYSE: USNA) is building a state-of-the-art facility in Beijing. The approximately $40 million structure will house world-class manufacturing and production operations. Upon completion, the nearly 319,000-square-foot site will be the largest in all of USANA's 19 international markets.  

(Logo: http://photos.prnewswire.com/prnh/20120807/LA53885LOGO)

"Our plans to invest in a high-tech production facility in Beijing reflect the significant opportunity and potential we see for our business in mainland China," said Dave Wentz, USANA's chief executive officer. "At USANA, we demonstrate our commitment to providing our customers with the highest quality nutritionals by manufacturing essentially all of our products in-house. This amazing facility will further that commitment."

USANA has negotiated land usage rights for this new building with the Beijing Economic and Technological Development Area, which houses a number of high-tech industries. The company anticipates that construction on this facility will begin in 2014 and will be operational during the latter part of 2015. 

For more information about USANA's products and company, visit USANA.com.

About USANA
Founded in 1992, USANA Health Sciences (NYSE: USNA) is a U.S.-based nutritional company that manufactures high-quality supplements and personal care, energy and weight-management products in its FDA-registered facility in Salt Lake City. USANA's products, used by more than 600 professional athletes, are developed by the company's award-winning team of scientists and sold directly to Preferred Customers and Associates in 19 international markets. Learn more about USANA (www.USANA.com) and stay current with the official USANA blog (www.whatsupUSANA.com), like us on the USANA Facebook page (www.facebook.com/USANAhealthsciences), or follow USANA on Twitter (@USANAinc).

Safe Harbor
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act.  Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including global economic conditions generally, reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, adverse publicity risks, and risks associated with our international expansion.  The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.

Media Contact: Ashley Collins
Executive Director of PR, Social Media and Communications
USANA Health Sciences, Inc.
(801) 954-7629
media(at)us.usana(dot)com

SOURCE USANA Health Sciences Inc.